Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Photoaffinity substrates for P-glycoprotein.

W T Beck1, X D Qian

  • 1Department of Biochemical and Clinical Pharmacology, St. Jude Children's Research Hospital, Memphis, TN 38101.

Biochemical Pharmacology
|January 9, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Involvement of polypyrimidine tract-binding protein (PTBP1) in maintaining breast cancer cell growth and malignant properties.

Oncogenesis·2014
Same author

Knockdown of splicing factor SRp20 causes apoptosis in ovarian cancer cells and its expression is associated with malignancy of epithelial ovarian cancer.

Oncogene·2010
Same author

Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro.

Oncogene·2007
Same author

Cytotoxic signalling by inhibitors of DNA topoisomerase II.

Biochemical Society transactions·2001
Same author

Synthesis and in vitro antitumor activity of oligonucleotide-tethered and related platinum complexes.

Journal of medicinal chemistry·2001
Same author

Role of an inverted CCAAT element in human topoisomerase IIalpha gene expression in ICRF-187-sensitive and -resistant CEM leukemic cells.

Molecular pharmacology·2001
Same journal

Unraveling the multifaceted roles of the aryl hydrocarbon receptor in the central nervous system: neurogenesis, neural function, and disease.

Biochemical pharmacology·2026
Same journal

4-DMB, a diclofenac derivative, alleviates DSS-induced ulcerative colitis in mice by binding TNFR1 to inhibit inflammation.

Biochemical pharmacology·2026
Same journal

Calceolarioside B alleviates airway barrier dysfunction and inflammation via targeting P2Y<sub>6</sub>R in OVA-triggered asthma.

Biochemical pharmacology·2026
Same journal

The dual-faced pyruvate kinase M2 in tumors: From cytoplasmic metabolic gatekeeper to nuclear transcriptional coactivator.

Biochemical pharmacology·2026
Same journal

A [<sup>68</sup>Ga]-labeled PDGFRβ-targeting peptide PET probe for assessing MASH-related fibrosis in diet-induced preclinical models and human liver specimens.

Biochemical pharmacology·2026
Same journal

Targeting TAK1 to overcome cisplatin resistance in lung adenocarcinoma by rewiring the NF-κB and p53 signaling.

Biochemical pharmacology·2026
See all related articles

Compounds that inhibit P-glycoprotein (Pgp) function are key to anticancer drug efficacy. A photoaffinity analog of daunorubicin ([3H]AB-DNR) effectively labels Pgp binding sites, revealing structural insights.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Molecular Biology

Background:

  • P-glycoprotein (Pgp) is a crucial efflux pump involved in multidrug resistance.
  • Inhibitors of Pgp can enhance anticancer drug efficacy by preventing substrate efflux.
  • The precise drug-binding site(s) within Pgp remain largely uncharacterized.

Purpose of the Study:

  • To explore the fundamental principles of drug recognition by Pgp.
  • To evaluate photoaffinity labeling compounds for identifying Pgp drug-binding sites.
  • To characterize a novel photoaffinity analog of daunorubicin for Pgp studies.

Main Methods:

  • Discussion of established concepts in Pgp drug recognition.
  • Examination of compounds utilized for photoaffinity labeling of Pgp.

Related Experiment Videos

  • Affinity labeling experiments using [3H]azidobenzoyl-daunorubicin ([3H]AB-DNR).
  • Competitive binding assays to assess drug interactions with Pgp.

    • Main Results:

    • [3H]azidobenzoyl-daunorubicin ([3H]AB-DNR) serves as an effective affinity labeling reagent for Pgp.
    • Vinblastine and verapamil exhibit stronger competition than daunorubicin for [3H]AB-DNR binding to Pgp.
    • These findings suggest shared structural features between vinblastine and verapamil relevant to Pgp binding.

    Conclusions:

    • Photoaffinity labeling with [3H]AB-DNR provides valuable insights into Pgp drug-binding sites.
    • Structural similarities exist between vinblastine, verapamil, and Pgp binding sites.
    • Understanding these interactions can inform the design of novel Pgp modulators for cancer therapy.